Summary
89.92 0.52(0.58%)07/11/2025
Medtronic plc (MDT)
MDT reported last earnings on 2025-05-21 after the market. An EPS of $1.62 was observed compared to an estimated EPS of $1.58, resulting in a surprise value of $0.04. A revenue of $8,927 million was observed compared to an estimated revenue of $8,819 million, resulting in a surprise value of $108 Million.
Medtronic plc (MDT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| -0.31 | 2.57 | 2.97 | 9.37 | 11.73 | 19.00 | 9.86 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B+ |
| Recommended Rating | Neutral |
| DCF | Buy |
| ROE | Buy |
| ROA | Buy |
| Debt/Equity | Strong Sell |
| P/E | Sell |
| P/B | Neutral |
Earnings
| Trading Data | ||
| Close | 89.65 | |
| Open | 89.75 | |
| High | 90.24 | |
| Low | 88.98 | |
| Volume | 6,226,387 | |
| Change | -0.28 | |
| Change % | -0.31 | |
| Avg Volume (20 Days) | 8,194,730 | |
| Volume/Avg Volume (20 Days) Ratio | 0.76 | |
| 52 Week Range | 74.56 - 94.71 | |
| Price vs 52 Week High | -5.35% | |
| Price vs 52 Week Low | 20.23% | |
| Range | 0.00 | |
| Gap Up/Down | 1.28 | |
Profitibility | ||
| Market Capitalization (Mln) | 113,622 | |
| Revenue per share | 26.1538 | |
| Net Income per share | 3.6364 | |
| Dividend Yield | 0.0390 | |
| Dividend Share | 351.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 24.7275 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
07/11 04:25 EST - fool.com
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
One of the good things about the healthcare sector is that most medical care isn't optional. This is the foundation behind the sector, but on that foundation sits the growth opportunity that comes with medical advances.
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
One of the good things about the healthcare sector is that most medical care isn't optional. This is the foundation behind the sector, but on that foundation sits the growth opportunity that comes with medical advances.
07/11 03:55 EST - fool.com
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks.
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks.
07/09 04:31 EST - fool.com
1 No-Brainer Dividend Stock to Buy Now and Hold Forever
Publicly traded corporations are under no obligation to pay dividends. Among those that do, many are rather subpar in the exercise, particularly with how often they raise their payouts.
1 No-Brainer Dividend Stock to Buy Now and Hold Forever
Publicly traded corporations are under no obligation to pay dividends. Among those that do, many are rather subpar in the exercise, particularly with how often they raise their payouts.
07/08 13:10 EST - 247wallst.com
BofA Securities Top Q3 Stocks Picks Feature 4 Incredible Dividend Ideas
Dividend stocks are a favorite among investors for good reason.
BofA Securities Top Q3 Stocks Picks Feature 4 Incredible Dividend Ideas
Dividend stocks are a favorite among investors for good reason.
07/08 08:45 EST - prnewswire.com
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
GALWAY, Ireland , July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July...
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
GALWAY, Ireland , July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July...
07/01 07:02 EST - marketbeat.com
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
Dividend yield is a commonly used metric for finding dividend stocks to buy and hold. The dividend yield is the amount of a company's dividend as a percentage of its stock price.
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
Dividend yield is a commonly used metric for finding dividend stocks to buy and hold. The dividend yield is the amount of a company's dividend as a percentage of its stock price.
06/30 18:51 EST - zacks.com
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
Medtronic (MDT) closed the most recent trading day at $87.17, moving +1.34% from the previous trading session.
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
Medtronic (MDT) closed the most recent trading day at $87.17, moving +1.34% from the previous trading session.
06/29 06:55 EST - seekingalpha.com
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
Initiate Medtronic with Strong Buy, $161 PT, citing a structural margin inflection from Diabetes spin-off and robust innovation pipeline (120+ approvals). Street underestimates FY27 margin/EPS upside from Diabetes separation and operating leverage in Cardiac & Structural Heart—key drivers for...
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
Initiate Medtronic with Strong Buy, $161 PT, citing a structural margin inflection from Diabetes spin-off and robust innovation pipeline (120+ approvals). Street underestimates FY27 margin/EPS upside from Diabetes separation and operating leverage in Cardiac & Structural Heart—key drivers for...
06/28 06:13 EST - seekingalpha.com
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
I reiterate my buy rating on Medtronic, driven by solid fundamentals and an attractive valuation, despite less upside versus prior estimates. Medtronic continues to deliver steady revenue growth, robust free cash flow, and a 48-year dividend growth streak, even as sector sentiment weakens. Key...
Medtronic: Eyes On The Pipeline And Spin, Shares Still Cheap
I reiterate my buy rating on Medtronic, driven by solid fundamentals and an attractive valuation, despite less upside versus prior estimates. Medtronic continues to deliver steady revenue growth, robust free cash flow, and a 48-year dividend growth streak, even as sector sentiment weakens. Key...
06/26 10:20 EST - zacks.com
BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?
Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two prominent companies with a strong foothold in this space are Boston Scientific BSX and Medtronic...
BSX vs. MDT: Which MedSurg Stock Is the Better Investment Now?
Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two prominent companies with a strong foothold in this space are Boston Scientific BSX and Medtronic...
06/26 08:45 EST - fool.com
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
06/24 08:00 EST - seekingalpha.com
2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'
Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. I highlight two such names that are undervalued compared to historical norms while paying strong and well-covered dividends. Both carry moat-worthy attributes and provide economically essential products and services...
2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'
Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. I highlight two such names that are undervalued compared to historical norms while paying strong and well-covered dividends. Both carry moat-worthy attributes and provide economically essential products and services...
06/23 16:15 EST - prnewswire.com
Medtronic Board appoints Dr. Joon Lee as a new director
GALWAY, Ireland , June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will...
Medtronic Board appoints Dr. Joon Lee as a new director
GALWAY, Ireland , June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will...
06/22 05:25 EST - fool.com
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better.
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better.
06/20 12:36 EST - zacks.com
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
06/19 09:22 EST - seekingalpha.com
6 Upcoming Dividend Increases
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increase and a 19.5-year streak, but none outperformed the SCHD ETF over the past decade. While SCHD...
6 Upcoming Dividend Increases
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increase and a 19.5-year streak, but none outperformed the SCHD ETF over the past decade. While SCHD...
06/17 08:00 EST - seekingalpha.com
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-covered dividends. Both carry A/A+ rated balance sheets and have potential for strong total returns...
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-covered dividends. Both carry A/A+ rated balance sheets and have potential for strong total returns...
06/15 23:21 EST - seekingalpha.com
Medtronic: Solid Recent Performance But Better Options Available
Medtronic remains a dependable dividend aristocrat, but its long-term total shareholder returns lag significantly behind peers like Johnson & Johnson and Stryker. Despite a solid 2025 performance, the stock's recent gains stem from a low base, and it still trades well below its 2021 highs. Earnings...
Medtronic: Solid Recent Performance But Better Options Available
Medtronic remains a dependable dividend aristocrat, but its long-term total shareholder returns lag significantly behind peers like Johnson & Johnson and Stryker. Despite a solid 2025 performance, the stock's recent gains stem from a low base, and it still trades well below its 2021 highs. Earnings...
06/13 10:27 EST - benzinga.com
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial minority IPO carve-out followed by a split-off of the remaining stake.
Medtronic Is Separating Its Diabetes Business - Good News For Investors
Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction – an initial minority IPO carve-out followed by a split-off of the remaining stake.
06/13 04:45 EST - fool.com
3 Monster Dividend Stocks to Hold for the Next 10 Years
The S&P 500 index (^GSPC 0.38%) is offering a minuscule 1.2% average yield today. That's not much to support a dividend-focused investor's income needs and speaks to a market that is richly valued.
3 Monster Dividend Stocks to Hold for the Next 10 Years
The S&P 500 index (^GSPC 0.38%) is offering a minuscule 1.2% average yield today. That's not much to support a dividend-focused investor's income needs and speaks to a market that is richly valued.